Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
18,894,149
-
Share change
-
+18,894,149
-
Total reported value
-
$595,167,000
-
Price per share
-
$31.50
-
Number of holders
-
50
-
Value change
-
+$595,166,610
-
Number of buys
-
50
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2014
As of 30 Sep 2014,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,894,149 shares.
The largest 10 holders included
Third Rock Ventures, LLC, FMR LLC, ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, RS INVESTMENT MANAGEMENT CO LLC, ALLIANCEBERNSTEIN L.P., PERCEPTIVE ADVISORS LLC, FEDERATED INVESTORS INC /PA/, FRANKLIN RESOURCES INC, and BlackRock Fund Advisors.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.